Therapeutic Challenges Posed by Critical Drug-Drug Interactions in Cystic Fibrosis

Pediatric Pulmonology - United States
doi 10.1002/ppul.23505
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Cystic Fibrosis–Related Diabetes: Pathophysiology and Therapeutic Challenges

Clinical Medicine Insights: Endocrinology and Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Identifying Drug–Drug Interactions by Data Mining

Circulation. Cardiovascular quality and outcomes
MedicineCardiovascular MedicineCardiology
2016English

Drug-Drug Interactions

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
2013English

Drug-Induced Dyspnea Versus Cystic Fibrosis Exacerbation: A Diagnostic Dilemma

International Medical Case Reports Journal
Medicine
2017English

NOACs: Drug-Drug Interactions

CMAJ
Medicine
2016English

Data-Driven Prediction of Adverse Drug Reactions Induced by Drug-Drug Interactions

BMC pharmacology & toxicology
MedicinePharmacology
2017English

Alterations of Chemotherapeutic Pharmacokinetic Profiles by Drug–drug Interactions

Expert Opinion on Drug Metabolism and Toxicology
MedicineToxicologyPharmacology
2009English

Modeling the Impact of Drug Interactions on Therapeutic Selectivity

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2018English

Drug–drug–gene Interactions and Adverse Drug Reactions

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy